Table 1 Associations between COMP expression in stroma and cancer cells and clinicopathological characteristics

152 (100)

70 (45.5)

38 (24.7)

26 (16.9)

18 (11.7)

66 (43.4)

56 (36.8)

16 (10.5)

12 (7.9)

152 (100)

28 (18.2)

13 (46.4)

6 (21.4)

7 (25.0)

2 (7.1)

0.211^a

8 (28.6)

14 (50.0)

2 (7.1)

3 (10.7

0.110^a

87 (56.5)

41 (47.1)

20 (23.0)

15 (17.2)

11 (12.6)

37 (42.5)

32 (36.8)

12 (13.8)

5 (5.7)

37 (24.0)

16 (43.2)

12 (32.4)

4 (10.8)

5 (13.5)

21 (56.8)

10 (27.0)

2 (5.4)

4 (10.8)

152 (100)

89 (58.6)

34 (37.8)

22 (24.4)

18 (20.0)

15 (16.7)

0.005^b

33 (37.1)

37 (41.6)

12 (13.5)

6 (13.0)

0.108^b

63 (41.4)

36 (56.3)

16 (25.0)

8 (12.5)

3 (4.7)

33 (52.4)

19 (30.2)

4 (6.3)

6 (5.7)

152 (100)

106 (69.7)

47 (43,9)

25 (23.4)

21 (19.6)

13 (12.1)

0.360^b

50 (47.2)

39 (36.8)

11 (10.4)

6 (5.7)

0.130^b

46 (30.3)

23 (48.9)

13 (27.7)

5 (10.6)

5 (10.6)

16 (34.8)

17 (37.0)

5 (10.9)

6 (13.0)

138 (90.7)

26 (17.1)

14 (53.8)

8 (30.8)

3 (11.5)

1 (3.8)

0.005^a

14 (53.8)

4 (15.4)

2 (7.7)

6 (23.1)

0.522^a

18 (11.8)

11 (61.1)

3 (16.7)

1 (5.6)

3 (16.7)

9 (50.0)

6 (33.3)

1 (5.6)

2 (11.1)

73 (48.0)

30 (40.5)

21 (28.4)

15 (20.3)

7 (9.5)

32 (43.8)

31 (42.5)

7 (9.6)

2 (2.7)

21 (13.8)

6 (27.3)

4 (18.2)

4 (18.2)

7 (31.8)

6 (28.6)

10 (47.6)

3 (14.3)

2 (9.5)

150 (98.7)

0.019^a

0.664^a

35 (23.0)

18 (51.4)

10 (28.6)

6 (17.1)

1 (2.9)

12 (34.3)

14 (40.0)

4 (11.4)

3 (8.6)

47 (30.9)

23 (48.9)

14 (29.8)

7 (14.9)

3 (6.4)

25 (53.2)

12 (25.5)

5 (10.6)

5 (10.6)

68 (44.7)

27 (39.7)

14 (20.6)

13 (19.1)

14 (20.6)

29 (42.6)

28 (41.2)

7 (10.3)

4 (5.9)